Logo

EU approves sale of new Alzheimer's drug, with conditions

EU approves sale of new Alzheimer's drug, with conditions

The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for early-stage Alzheimer's disease, to be sold in the EU under strict conditions.

👉 Full Story